Yahoo Finance

Abbott Laboratories (ABT) reported weaker-than-expected fourth quarter sales due to weakness in its nutrition and diagnostics units. The company's full-year outlook met estimates as medical device demand is expected to continue to grow.

Catalysts Hosts Seana Smith and Madison Mills discuss the company's medical device sales, which saw double-digit gains in the quarter.

To watch more expert insights and analysis on the latest market action, check out more Catalysts here.